ENZN
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Aug 22 closing price
Capitalization
5.88M
TECH
Price
$56.73
Change
-$0.36 (-0.63%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
8.95B
71 days until earnings call
Interact to see
Advertisement

ENZN vs TECH

Header iconENZN vs TECH Comparison
Open Charts ENZN vs TECHBanner chart's image
Enzon Pharmaceuticals
Price$0.08
Change-$0.00 (-0.00%)
Volume$13.63K
Capitalization5.88M
Bio-Techne
Price$56.73
Change-$0.36 (-0.63%)
Volume$66.66K
Capitalization8.95B
ENZN vs TECH Comparison Chart in %
Loading...
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENZN vs. TECH commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENZN is a Hold and TECH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (ENZN: $0.08 vs. TECH: $57.09)
Brand notoriety: ENZN and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENZN: 16% vs. TECH: 68%
Market capitalization -- ENZN: $5.88M vs. TECH: $8.95B
ENZN [@Biotechnology] is valued at $5.88M. TECH’s [@Biotechnology] market capitalization is $8.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENZN’s FA Score shows that 1 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • ENZN’s FA Score: 1 green, 4 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, TECH is a better buy in the long-term than ENZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENZN’s TA Score shows that 2 TA indicator(s) are bullish while TECH’s TA Score has 6 bullish TA indicator(s).

  • ENZN’s TA Score: 2 bullish, 6 bearish.
  • TECH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TECH is a better buy in the short-term than ENZN.

Price Growth

ENZN (@Biotechnology) experienced а +0.25% price change this week, while TECH (@Biotechnology) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Reported Earning Dates

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($8.95B) has a higher market cap than ENZN($5.88M). TECH has higher P/E ratio than ENZN: TECH (124.11) vs ENZN (96.10). TECH YTD gains are higher at: -20.398 vs. ENZN (-49.263). TECH has higher annual earnings (EBITDA): 283M vs. ENZN (-1.49M). ENZN has less debt than TECH: ENZN (116M) vs TECH (423M). TECH has higher revenues than ENZN: TECH (1.21B) vs ENZN (0).
ENZNTECHENZN / TECH
Capitalization5.88M8.95B0%
EBITDA-1.49M283M-1%
Gain YTD-49.263-20.398242%
P/E Ratio96.10124.1177%
Revenue01.21B-
Total Cash44.3MN/A-
Total Debt116M423M27%
FUNDAMENTALS RATINGS
ENZN vs TECH: Fundamental Ratings
ENZN
TECH
OUTLOOK RATING
1..100
261
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9980
PRICE GROWTH RATING
1..100
6454
P/E GROWTH RATING
1..100
1111
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is significantly better than the same rating for ENZN (85). This means that TECH’s stock grew significantly faster than ENZN’s over the last 12 months.

TECH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ENZN (100). This means that TECH’s stock grew similarly to ENZN’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as ENZN (99). This means that TECH’s stock grew similarly to ENZN’s over the last 12 months.

TECH's Price Growth Rating (54) in the Biotechnology industry is in the same range as ENZN (64). This means that TECH’s stock grew similarly to ENZN’s over the last 12 months.

TECH's P/E Growth Rating (11) in the Biotechnology industry is in the same range as ENZN (11). This means that TECH’s stock grew similarly to ENZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENZNTECH
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 8 days ago
74%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRO15.830.89
+5.96%
Pros Holdings
DTSS1.910.07
+3.93%
Datasea
OTTR85.972.88
+3.47%
Otter Tail Corp
CYBN7.150.23
+3.32%
Cybin Inc
ALAB179.091.56
+0.88%
Astera Labs

ENZN and

Correlation & Price change

A.I.dvisor tells us that ENZN and LPCN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENZN and LPCN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENZN
1D Price
Change %
ENZN100%
-4.30%
LPCN - ENZN
24%
Poorly correlated
+3.32%
CLDX - ENZN
9%
Poorly correlated
+2.00%
HALO - ENZN
7%
Poorly correlated
+0.29%
INCY - ENZN
4%
Poorly correlated
-1.72%
TECH - ENZN
4%
Poorly correlated
+5.72%
More